Cushing’s Syndrome: Screening and Diagnosis
Abstract
Endogenous Cushing's syndrome (CS) is a rare disease, and usually characterized by hypertension, diabetes, obesity, osteoporosis, facial rounding, dorsocervical fat pad, thin skin, purple striae, hirsutism, and mood disorders. Efficient diagnostic and screening strategies lead to the diagnosis of a significantly higher number of cases of CS. As a screening test for CS, the Endocrine Society's Clinical Practice Guidelines recommend a single test with a high diagnostic accuracy, among the 1-mg dexamethasone suppression test (1-mg DST), late night salivary cortisol (LNSC), and 24 h urinary free cortisol (UFC). In normal subjects, administering a higher than physiological dose of glucocorticoids prompts the suppression of cortisol secretion. The 1-mg DST explores this normal feedback reaction from the hypothalamic-pituitary-adrenal axis (HPA). It is a simple dynamic test, usually performed in outpatients. A morning serum cortisol level <50 nmol/L suffices to exclude CS, unless there is a strong clinical suspicion to suggest otherwise. The HPA axis reaches a nadir just after a person has fallen asleep, but its circadian rhythm is impaired in CS patients, who feature higher cortisol values at night, which are easy to measure in saliva (the LNSC assay). Saliva collection is also suitable for outpatients since cortisol is stable at room temperature and the collection device can be mailed to the laboratory for analysis. UFC levels reflect the integrated tissue exposure to free cortisol over 24 h, and thus provide a particular picture of endogenous hypercortisolism. In most cases, high UFC levels coincide with severe hypercortisolism. UFC is used not only to diagnose CS, but also to monitor its response to medical treatment. All screening tests have procedural snares: some drugs can interfere with the DST; false-positive or false-negative LNSC results may be due to an inadequate soaking of the device or to cyclic CS; and in the case of UFC it is important to ensure that patients provide complete urine collections with appropriate total volumes. Measuring cortisol with antibody-based immunoassays can also generate false-positive results due to cross-reactivity between cortisol, cortisone and other metabolites. Structurally-based assays, such as liquid chromatography with tandem mass spectrometry, only measure cortisol and have only recently become available for use in routine clinical practice. This review summarizes the recent literature on the clinical and biochemical aspects of CS diagnostics with a view to helping physicians choose the best screening test for diagnosing endogenous hypercortisolism.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Serum cortisol below 50 nmol/L after DST makes Cushing's syndrome very unlikely, while a value above 138 nmol/L makes it likely.
“It is widely accepted that serum cortisol levels <50 nmol/L after DST makes CS diagnosis very unlikely, whereas a value >138 nmol/L makes CS likely [38].”
From Salivary cortisol and cortisone in diagnosis of Cushing's syndrome: a comparison of six different analytical methods (2023) · cites this paper as [38]
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 9× · see citing works
“Medication may impair dexamethasone metabolism, causing falsely abnormal results [1, 17]: dexamethasone is metabolized by the CYP3A4 complex, which is Fig.”
BackgroundInfluentialIlias, Ι., Torpy, D. J., Pacák, K., Mullen, N., WESLEY, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 713 · see citing works
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562 · see citing works
Anderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403 · see citing works
Handelsman, D. J., & Wartofsky, L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3375 · Cited by 368 · see citing works
Approach to the Patient with Possible Cushing’s Syndrome
Boscaro, M., & Arnaldi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0612 · Cited by 251 · see citing works
Self-citationAccuracy of Diagnostic Tests for Cushing’s Syndrome: A Systematic Review and Metaanalyses
Elamin, M. B., Murad, M. H., Mullan, R., Erickson, D., Harris, K., Nadeem, S., Ennis, R., Erwin, P. J., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0139 · Cited by 222 · see citing works
The hypertension of Cushing's syndrome
Isidori, A. M., Graziadio, C., Paragliola, R. M., Cozzolino, A., Ambrogio, A. G., Colao, A., Corsello, S. M., & Pivonello, R. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000415 · Cited by 220 · see citing works
Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion
Ejaz, S., Vassilopoulou‐Sellin, R., Busaidy, N. L., Hu, M. I.-N., Waguespack, S. G., Jiménez, C., Ying, A. K., Cabanillas, M. E., Abbara, M., & Habra, M. A. (2011) · Cancer · doi:10.1002/cncr.26029 · Cited by 179 · see citing works
Subclinical hypercortisolism among outpatients referred for osteoporosis.
Chiodini, I., Mascia, M. L., Muscarella, S., Battista, C., Minisola, S., Arosio, M., Santini, S. A., Guglielmi, G., Carnevale, V., & Scillitani, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00006 · Cited by 162 · see citing works
Pecori Giraldi, F., Ambrogio, A. G., De Martin, M., Fatti, L. M., Scacchi, M., & Cavagnini, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0596 · Cited by 121 · see citing works
Antonelli, G., Ceccato, F., Artusi, C., Marinova, M., & Plebani, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.004 · Cited by 111 · see citing works
Self-citationElias, P. C. L., Martinez, E. Z., Barone, B. F. C., Mermejo, L. M., Castro, M., & Moreira, A. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4262 · Cited by 90 · see citing works
Terzolo, M., Reimondo, G., Chiodini, I., Castello, R., Giordano, R., Ciccarelli, E., Limone, P., Crivellaro, C., Martinelli, I., Montini, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1323 · Cited by 89 · see citing works
Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS
Ceccato, F., Barbot, M., Zilio, M., Frigo, A. C., Albiger, N. M. E., Camozzi, V., Antonelli, G., Plebani, M., Mantero, F., Boscaro, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2507 · Cited by 81 · see citing works
Self-citationDeutschbein, T., Broecker-Preuss, M., Flitsch, J., Jaeger, A., Althoff, R., Walz, M. K., Mann, K., & Petersenn, S. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0945 · Cited by 81 · see citing works
Valassi, E., Swearingen, B., Lee, H., Nachtigall, L. B., Donoho, D. A., Klibanski, A., & Biller, B. M. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1500 · Cited by 78 · see citing works
Ceccato, F., Barbot, M., Zilio, M., Ferasin, S., Occhi, G., Daniele, A., Mazzocut, S., Iacobone, M., Betterle, C., Mantero, F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0159 · Cited by 75 · see citing works
Self-citationCushing’s syndrome: diagnosis and surveillance using salivary cortisol
Raff, H. (2011) · Pituitary · doi:10.1007/s11102-011-0333-0 · Cited by 70 · see citing works
Martins, L. C., Conceição, F. L., Muxfeldt, E. S., & Salles, G. F. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283521484 · Cited by 61 · see citing works
Ceccato, F., Antonelli, G., Barbot, M., Zilio, M., Mazzai, L., Gatti, R. D., Zaninotto, M., Mantero, F., Boscaro, M., Plebani, M., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0061 · Cited by 56 · see citing works
Self-citationIs urinary free cortisol of value in the diagnosis of Cushing's syndrome?
Alexandraki, K., & Grossman, A. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283487193 · Cited by 55 · see citing works
Erickson, D. Z., Singh, R., Sathananthan, A., Vella, A. V., & Bryant, S. C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04239.x · Cited by 50 · see citing works
Endocrine hypertension: An overview on the current etiopathogenesis and management options
Thomas, R. M. (2015) · World Journal of Hypertension · doi:10.5494/wjh.v5.i2.14 · Cited by 40 · see citing works
Graham, U. M., Hunter, S. J., McDonnell, M., Mullan, K., & Atkinson, A. B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2925 · Cited by 26 · see citing works
Screening for secondary endocrine hypertension in young patients.
Trifanescu, R. A., Carşote, M., Caragheorgheopol, A., Hortopan, D., Dumitrascu, A. S., Dobrescu, M., & Poiană, C. (2013) · Europe PMC (PubMed Central) · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Saliva diagnostics – Current views and directions
Kaczor‐Urbanowicz, K. E., Carreras‐Presas, C. M., Aro, K. L. S., Tu, M. K., Garcı́a-Godoy, F., & Wong, D. T. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216681550 · Cited by 482 · see citing works
Promising applications of human-derived saliva biomarker testing in clinical diagnostics
Song, M., Bai, H., Zhang, P., Zhou, X., & Ying, B. (2023) · International Journal of Oral Science · doi:10.1038/s41368-022-00209-w · Cited by 223 · see citing works
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
Barbot, M., Zilio, M., & Scaroni, C. M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101380 · Cited by 122 · see citing works
Perrin, A. J., Horowitz, M. A., Roelofs, J., Zunszain, P. A., & Pariante, C. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00423 · Cited by 98 · see citing works
Vignesh, V., Dominguez, B. C., James, T. D., Turner‐Cobb, J. M., Lightman, S. L., & Reis, N. M. (2024) · ACS Sensors · doi:10.1021/acssensors.3c01912 · Cited by 102 · see citing works
Autonomous cortisol secretion in adrenal incidentalomas
Castro, M. A., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-01888-y · Cited by 76 · see citing works
Ceccato, F., Artusi, C., Barbot, M., Lizzul, L., Pinelli, S., Costantini, G., Niero, S., Antonelli, G., Plebani, M., & Scaroni, C. M. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01197-6 · Cited by 74 · see citing works
Self-citationMetyrapone treatment in Cushing’s syndrome: a real-life study
Ceccato, F., Zilio, M., Barbot, M., Albiger, N. M. E., Antonelli, G., Plebani, M., Watutantrige‐Fernando, S., Sabbadin, C., Boscaro, M., & Scaroni, C. M. (2018) · Endocrine · doi:10.1007/s12020-018-1675-4 · Cited by 69 · see citing works
Self-citationPituitary Tumors Centers of Excellence.
Frara, S., Rodríguez-Carnero, G., Formenti, A. M., Olmos, M. M., Giustina, A., & Casanueva, F. (2020) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2020.05.010 · Cited by 62 · see citing works
Approach to patients with pseudo-Cushing’s states
Scaroni, C., Albiger, N. M., Palmieri, S., Iacuaniello, D., Graziadio, C., Damiani, L., Zilio, M., Stigliano, A., Colao, A., Pivonello, R., et al. (2020) · Endocrine Connections · doi:10.1530/ec-19-0435 · Cited by 68 · see citing works
Biochemical analysis of oral fluids for disease detection
Khurshid, Z., Warsi, I., Moin, S. F., Slowey, P. D., Latif, M., Zohaib, S., & Zafar, M. S. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.04.005 · Cited by 64 · see citing works
Progress in salivary glands: Endocrine glands with immune functions
Shang, Y. F., Shen, Y. Y., Zhang, M. C., Lv, M. C., Wang, T. Y., Chen, X. Q., & Lin, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1061235 · Cited by 52 · see citing works
Ceccato, F., Barbot, M., Mondin, A., Boscaro, M., Fleseriu, M., & Scaroni, C. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac686 · Cited by 50 · see citing works
Self-citationOßwald, A., Wang, R., Beuschlein, F., Hartmann, M. F., Wudy, S. A., Bidlingmaier, M., Zopp, S., Reincke, M., & Ritzel, K. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.004 · Cited by 42 · see citing works
Diagnostic workup of Cushing’s syndrome
Balomenaki, M., Margaritopoulos, D., Vassiliadi, D. A., & Tsagarakis, S. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13111 · Cited by 41 · see citing works
Endocrine hypertension: An overview on the current etiopathogenesis and management options
Thomas, R. M. (2015) · World Journal of Hypertension · doi:10.5494/wjh.v5.i2.14 · Cited by 40 · see citing works
Glucocorticoids Influencing Wnt/β-Catenin Pathway; Multiple Sites, Heterogeneous Effects
Mészáros, K. V., & Patócs, A. (2020) · Molecules · doi:10.3390/molecules25071489 · Cited by 37 · see citing works
Bileck, A., Verouti, S. N., Escher, G., Vogt, B., & Groessl, M. (2018) · The Analyst · doi:10.1039/c7an01990d · Cited by 34 · see citing works
Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01615-3 · Cited by 34 · see citing works
Self-citationCeccato, F., Tizianel, I., Vedolin, C. K., Boscaro, M., Barbot, M., & Scaroni, C. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa564 · Cited by 33 · see citing works
Self-citationMechanism, diagnosis, and treatment of cyclic Cushing’s syndrome: A review
Cai, Y., Ren, L., Tan, S.-W., Liu, X., Li, C., Gang, X., & Wang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113301 · Cited by 31 · see citing works
Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome
Findling, J. W., & Raff, H. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad087 · Cited by 30 · see citing works
A multidisciplinary approach to the management of adrenal incidentaloma
Voltan, G., Boscaro, M., Armanini, D., Scaroni, C. M., & Ceccato, F. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1948327 · Cited by 27 · see citing works
Self-citationEmerging diagnostic methods and imaging modalities in cushing’s syndrome
Wright, K. E., van Rossum, E. F. C., Zan, E., Werner, N. L., Harris, A. G., Feelders, R. A., & Agrawal, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230447 · Cited by 25 · see citing works
Second-Line Tests in the Diagnosis of Adrenocorticotropic Hormone-Dependent Hypercortisolism
Pinelli, S., Barbot, M., Scaroni, C. M., & Ceccato, F. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.6.521 · Cited by 23 · see citing works
Self-citationGrasso, M., Boscaro, M., Scaroni, C. M., & Ceccato, F. (2018) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0288-6 · Cited by 22 · see citing works
Self-citationThe Demystification of Secondary Hypertension: Diagnostic Strategies and Treatment Algorithms
Hirsch, J. S., & Hong, S. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0790-8 · Cited by 21 · see citing works
Osilodrostat: A Novel Steroidogenesis Inhibitor to Treat Cushing’s Disease
Dougherty, J., Desai, D., & Herrera, J. B. (2020) · The Annals of Pharmacotherapy · doi:10.1177/1060028020968808 · Cited by 15 · see citing works
Bäcklund, N., Brattsand, G., Lundstedt, S., Aardal, E., Bartuseviciene, I., Berinder, K., Höybye, C., Burman, P., Edén Engström, B., Isaksson, A., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0141 · Cited by 9 · see citing works
Subtyping of Cushing’s Syndrome: A Step Ahead
Tizianel, I., Barbot, M., & Ceccato, F. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2299-5065 · Cited by 9 · see citing works
Self-citationWnt-Signaling Regulated by Glucocorticoid-Induced miRNAs
Butz, H., Mészáros, K. V., Likó, I., & Patócs, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111778 · Cited by 10 · see citing works
Hypertension in Cushing’s Syndrome
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_8 · Cited by 9 · see citing works
Self-citationIwamoto, Y., Tatsumi, F., Itoh, T., Sasaki, T., Mori, S., Sugisaki, T., Nakao, E., Ohnishi, M., Kusano, T., Takenouchi, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22676-1 · Cited by 8 · see citing works
A dilute and shoot method for urinary free cortisol analysis by LC-MS/MS
Shen, Y., Luo, X., Guan, Q., & Cheng, L. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124127 · Cited by 8 · see citing works
Choosing which in-hospital laboratory tests to target for intervention: a scoping review
Podolsky, E., Hudek, N., McCudden, C. R., Presseau, J., Yanikomeroglu, S., Brouwers, M. C., & Brehaut, J. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0910 · Cited by 9 · see citing works
Diagnostic value of salivary cortisol in 1-mg dexamethasone suppression test
Belaya, Z. E., Malygina, A. A., Grebennikova, T. A., Il'yin, A. V., Rozhinskaya, L. Y., Fadeev, V. V., Mel'nichenko, G. A., & Dedov, I. I. (2020) · Obesity and metabolism · doi:10.14341/omet10117 · Cited by 7 · see citing works
Who and how to screen for endogenous hypercortisolism in adrenal and pituitary incidentaloma
Coscia, K., Verrienti, M., Dalmazi, G. D., & Zatelli, M. C. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02456-6 · Cited by 6 · see citing works
The patient’s sex determines the hemodynamic profile in patients with Cushing disease
Jurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Kazimierczak, A., Wierzbowski, R., Banak, M., & Gielerak, G. G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1270455 · Cited by 6 · see citing works
Whole blood transcriptomic signature of Cushing's syndrome
Birtolo, M. F., Armignacco, R., Benanteur, N., Baussart, B., Villa, C., Murat, D. D., Guignat, L., Groussin, L., Libé, R., Zennaro, M., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae083 · Cited by 6 · see citing works
Rivera-Martínez, W., Ramírez-Castaño, M. J., Cruz-Calderón, S., Díaz-Posada, N. A., Restrepo, J. G., Román-González, A., Henao, N. A., Ceballos, P. A. C., Tobón-Ospina, C. I., Gómez, J. D. D., et al. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261434078 · Cited by 4 · see citing works
Buonacera, A., Stancanelli, B., & Malatino, L. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0200-9 · Cited by 5 · see citing works
Glyn, T., Ho, M., Lambert, A. P., Thomas, J., Douek, I. F., Andrews, R. C., & King, R. (2020) · Clinical Obesity · doi:10.1111/cob.12358 · Cited by 5 · see citing works
Bliziotis, N. G., Kluijtmans, L. A. J., Tinnevelt, G. H., Reel, P. S., Reel, S., Langton, K., Robledo, M., Pamporaki, C., Pecori, A., van Kralingen, J. C., et al. (2022) · Metabolites · doi:10.3390/metabo12080679 · Cited by 5 · see citing works
Self-citationJurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Kazimierczak, A., Wierzbowski, R., Banak, M., & Gielerak, G. G. (2025) · Scientific Reports · doi:10.1038/s41598-024-84888-x · Cited by 4 · see citing works
Lam-Chung, C., & Ramos, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075785 · Cited by 4 · see citing works
Chen, X., Wang, D., Tao, J., & Zhang, A. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103067 · Cited by 3 · see citing works
Zhao, X., Xu, Z., Su, H., Zheng, R., Zhan, M., Huang, Y., & Su, Z. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03722-3 · Cited by 3 · see citing works
Katabami, T., Matsuba, R., Nagasaka, T., Yamamoto, Y., Sakai, K., & Sone, M. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0696 · Cited by 3 · see citing works
Obesity-Related Hemodynamic Alterations in Patients with Cushing’s Disease
Jurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Wierzbowski, R., Kazimierczak, A., Banak, M., & Gielerak, G. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061658 · Cited by 3 · see citing works
Wu, R., Hamden, J. E., Salehzadeh, M., Li, M. X., Poudel, A., Schmidt, K. L., Kobor, M. S., & Soma, K. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309478 · Cited by 2 · see citing works
Zhou, Z., Chai, W., Yang, L., Liu, Y., Liu, Y., Pan, H.-Y., Wu, Q., Zhang, X., & Roessner, E. D. (2022) · BMC Surgery · doi:10.1186/s12893-022-01674-0 · Cited by 2 · see citing works
Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis
Agrawal, N., Kim, H. H., Wright, K. E., & Mehta, S. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_10 · Cited by 2 · see citing works
Ambroziak, U., Kuryłowicz, A., Kępczyńska‐Nyk, A., Kondracka, A., Gajda, S., & Sieńko, D. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13628 · Cited by 1 · see citing works
Skin aging: Neuroendocrine challenge
Carşote, M., Şandru, F., Albu, S. E., Dumitrașcu, M. C., Petrova, E. N., & Valea, A. (2020) · Romanian Medical Journal · doi:10.37897/rmj.2020.1.5 · Cited by 1 · see citing works
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_9 · Cited by 1 · see citing works
Approccio al paziente con Pseudo-Cushing
Albiger, N. M. E., Barbot, M., Mondin, A., & Scaroni, C. M. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00906-4
Fukuda, M., Hamada, K., Shimizu, Y., & Tanaka, T. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-241080
Paraneoplastisch syndroom van Cushing
Soubry, E., Myngheer, N., & Vereecke, G. (2022) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.224
Januškevičiūtė, E., Kalakauskaitė, L., & Visockienė, Ž. (2022) · Lietuvos chirurgija · doi:10.15388/lietchirur.2022.21.57
Hipertensión arterial resistente en paciente obeso y diabético tipo 2
Luis-García, S., Gonzalo, L. A., Narciso, C. G. S., Jiménez-Segovia, F., & Torres-Do-Rego, A. (2022) · Revista Española de Casos Clínicos en Medicina Interna · doi:10.32818/reccmi.a7n1a9
Göz Hastalıklarında Güncel Çalışmalar IV
Atmaca, F., Karalezlı, A., Yaman, F., Kaderli, S. T., Pehlivanoğlu, S., Tekcan, H., Balcıoğlu, E., Özçelik, F., Alpoğan, O., Keser, S., et al. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2538
Dynamic Tests in Clinical Endocrinology
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch9
Neuroanesthesia for pituitary surgery
Solari, D., Cavallo, L. M., Domenico, C. D., & Cafiero, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22273-3.00016-x
Wang, M., Li, S., Cui, Q., Huang, B., & Cui, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1678472
Pieronne-Deperrois, M. (2022) · theses.fr (ABES) · doi:10.70675/71ef46cfz0230z4862za32aze1072fe4be66
Cut-off values of urinary free cortisol and cortisone for diagnosing neoplastic hypercortisolism
Koops, K., Hillebrand, J. J., Heijboer, A. C., & Bisschop, P. H. L. T. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121107
Skin as a mirror of endocrine diseases: emerging biomarkers and targeted therapies
Fuentes‐Mendoza, J. M., Concepción‐Zavaleta, M. J., Cruz, J. P. V.-D. L., Basurto-Ayala, A., Albarracin-Lescano, P., Aldave, J. E. Q., Urteaga, L. A. C., & Paz‐Ibarra, J. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2682580
Liu, Y., Yi, L., & Tan, H. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag361
- Authors
- Ceccato, F., & Boscaro, M.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Ceccato, Filippo
- Venue
- High Blood Pressure & Cardiovascular Prevention
- Published
- 2016-05-09
- Volume
- 23
- Issue
- 3
- Pages
- 209-215
- ISSN
- 1120-9879 (ISSN-L)
- 1179-1985
- OpenAlex
- W2346455887
- Cited by
- 70
- References
- 26
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 7 · 2020: 13 · 2019: 4 · 2018: 5 · 2017: 1 · 2016: 1 · 2015: 1
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- High Blood Pressure & Cardiovascular Prevention (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- Cushing's syndrome, endogenous hypercortisolism, screening test, dexamethasone suppression test, late-night salivary cortisol, 24-hour urinary free cortisol, hypothalamic-pituitary-adrenal axis, diurnal cortisol rhythm, false positives, immunoassay cross-reactivity, liquid chromatography-tandem mass spectrometry
- MeSH terms
- Adrenal Cortex Function Tests, Chromatography, Liquid, Circadian Rhythm, Cushing Syndrome, Dexamethasone, Humans, Hydrocortisone, Predictive Value of Tests, Prognosis, Risk Factors, Saliva, Severity of Illness Index, Biomarkers, Up-Regulation, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review